A panel of radiochemicals has enabled in vivo positron emission tomography (PET) of tau
pathologies in Alzheimer's disease (AD), although sensitive detection of frontotemporal lobar …

Objective The sigma 1 receptor is considered to be involved in cognitive function. A postmortem
study reported that the sigma 1 receptors were reduced in the hippocampus in Alzheimer…

2-((1E,3E)-4-(6-( 11 C-methylamino)pyridin-3-yl)buta-1,3-dienyl)benzo[d]thiazol-6-ol ( 11 C-PBB3)
is a clinically useful PET probe that we developed for in vivo imaging of tau pathology …

Tau accumulation in the brain is a pathologic hallmark of Alzheimer disease and other
tauopathies. Quantitative visualization of tau pathology in humans can be a powerful method as a …

The potential of the 11 C-labeled selective sigma 1 receptor ligand 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine
([ 11 C]SA4503) was evaluated in vivo as a positron …

Purpose The translocator protein (18 kDa) (TSPO) is highly expressed on the bronchial and
bronchiole epithelium, submucosal glands in intrapulmonary bronchi, pneumocytes and …

Tau deposits is a core feature of neurodegenerative disorder following traumatic brain injury
(TBI). Despite ample evidence from post-mortem studies demonstrating exposure to both …

P-glycoprotein (P-gp) regulates the ability of endogenous and exogenous compounds to
cross the blood–brain barrier. We investigated whether PET tracers used clinically for studying …

Although aberrations in the number and function of glutamate AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid) receptors are thought to underlie neuropsychiatric …

Synaptic dysfunction provoking dysregulated cortical neural circuits is currently hypothesized
as a key pathophysiological process underlying clinical manifestations in Alzheimer's …